Rockefeller Capital Management L.P. Sells 162,122 Shares of U.S. Physical Therapy, Inc. $USPH

Rockefeller Capital Management L.P. decreased its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 47.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 178,690 shares of the company’s stock after selling 162,122 shares during the period. Rockefeller Capital Management L.P.’s holdings in U.S. Physical Therapy were worth $13,954,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of USPH. Royal Bank of Canada raised its position in shares of U.S. Physical Therapy by 3.4% in the 1st quarter. Royal Bank of Canada now owns 79,238 shares of the company’s stock worth $5,733,000 after acquiring an additional 2,594 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in U.S. Physical Therapy by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,897 shares of the company’s stock worth $644,000 after purchasing an additional 391 shares during the period. Jane Street Group LLC grew its stake in U.S. Physical Therapy by 249.3% during the first quarter. Jane Street Group LLC now owns 49,309 shares of the company’s stock worth $3,568,000 after purchasing an additional 35,191 shares during the period. Hsbc Holdings PLC acquired a new stake in U.S. Physical Therapy during the second quarter worth approximately $410,000. Finally, First Trust Advisors LP increased its holdings in U.S. Physical Therapy by 3.7% in the second quarter. First Trust Advisors LP now owns 10,725 shares of the company’s stock worth $839,000 after purchasing an additional 385 shares in the last quarter.

Analyst Ratings Changes

Several brokerages have issued reports on USPH. Zacks Research raised U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 27th. Barrington Research reduced their price objective on shares of U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating for the company in a research report on Wednesday, May 13th. Citizens Jmp lowered their price objective on shares of U.S. Physical Therapy from $113.00 to $98.00 and set a “market outperform” rating for the company in a research note on Friday, May 8th. Jefferies Financial Group upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Thursday, March 12th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Friday, May 29th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $97.50.

Insider Buying and Selling

In other U.S. Physical Therapy news, Director Peter Francis Minan acquired 492 shares of the stock in a transaction on Monday, June 8th. The shares were purchased at an average price of $63.14 per share, for a total transaction of $31,064.88. Following the completion of the acquisition, the director owned 2,923 shares in the company, valued at approximately $184,558.22. This represents a 20.24% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 2.40% of the company’s stock.

U.S. Physical Therapy Stock Up 1.8%

Shares of NYSE:USPH opened at $63.65 on Wednesday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.19 and a current ratio of 1.19. U.S. Physical Therapy, Inc. has a 52-week low of $58.19 and a 52-week high of $93.50. The business’s 50 day simple moving average is $66.64 and its two-hundred day simple moving average is $75.79. The firm has a market cap of $968.75 million, a P/E ratio of 127.30, a PEG ratio of 1.73 and a beta of 1.16.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.46 EPS for the quarter, missing the consensus estimate of $0.55 by ($0.09). U.S. Physical Therapy had a net margin of 4.36% and a return on equity of 8.81%. The firm had revenue of $198.29 million for the quarter, compared to the consensus estimate of $200.94 million. During the same quarter in the prior year, the firm earned $0.48 EPS. The company’s revenue was up 7.9% compared to the same quarter last year. As a group, research analysts forecast that U.S. Physical Therapy, Inc. will post 2.99 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, June 12th. Shareholders of record on Friday, May 22nd were paid a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date was Friday, May 22nd. U.S. Physical Therapy’s payout ratio is 368.00%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.